Go Pro
→ Ticker Revealed: Pre-IPO Access to 'Next Elon Musk' Company (From Banyan Hill Publishing) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Diamondback Energy, Inc. stock logo
FANG
Diamondback Energy
$208.55
-0.7%		$191.03
$134.30
▼
$214.51
$58.81B0.431.82 million shs1.89 million shs
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$1,022.32
-1.7%		$1,055.05
$705.55
▼
$1,153.99
$302.96B1.31.87 million shs2.74 million shs
Moderna, Inc. stock logo
MRNA
Moderna
$174.38
+177.0%		$64.91
$22.28
▼
$176.66
$25.14B0.915.37 million shs194.97 million shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Diamondback Energy, Inc. stock logo
FANG
Diamondback Energy
+1.81%+4.12%+7.41%+2.78%+50.53%
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
-1.06%+0.67%-2.49%+5.88%+42.33%
Moderna, Inc. stock logo
MRNA
Moderna
-2.33%+3.95%+1.84%+30.84%+124.14%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Diamondback Energy, Inc. stock logo
FANG
Diamondback Energy
$208.55
-0.7%		$191.03
$134.30
▼
$214.51
$58.81B0.431.82 million shs1.89 million shs
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$1,022.32
-1.7%		$1,055.05
$705.55
▼
$1,153.99
$302.96B1.31.87 million shs2.74 million shs
Moderna, Inc. stock logo
MRNA
Moderna
$174.38
+177.0%		$64.91
$22.28
▼
$176.66
$25.14B0.915.37 million shs194.97 million shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Diamondback Energy, Inc. stock logo
FANG
Diamondback Energy
+1.81%+4.12%+7.41%+2.78%+50.53%
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
-1.06%+0.67%-2.49%+5.88%+42.33%
Moderna, Inc. stock logo
MRNA
Moderna
-2.33%+3.95%+1.84%+30.84%+124.14%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Diamondback Energy, Inc. stock logo
FANG
Diamondback Energy
2.96
Moderate Buy$221.756.33% Upside
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
2.54
Moderate Buy$1,062.863.97% Upside
Moderna, Inc. stock logo
MRNA
Moderna
2.05
Hold$56.56-67.56% Downside

Current Analyst Ratings Breakdown

Latest FANG, GS, and MRNA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/19/2026
Moderna, Inc. stock logo
MRNA
Moderna
Morgan Stanley logo
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingNeutral
8/19/2026
Moderna, Inc. stock logo
MRNA
Moderna
The Goldman Sachs Group, Inc. logo
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingNeutral$120.00
8/19/2026
Moderna, Inc. stock logo
MRNA
Moderna
Royal Bank Of Canada logo
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSector Perform$130.00
8/19/2026
Moderna, Inc. stock logo
MRNA
Moderna
Loop Capital logo
Loop Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$135.00
8/19/2026
Moderna, Inc. stock logo
MRNA
Moderna
Brookline Capital Markets logo
Brookline Capital Markets
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy
8/19/2026
Moderna, Inc. stock logo
MRNA
Moderna
Jefferies Financial Group Inc. logo
Jefferies Financial Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold
8/19/2026
Diamondback Energy, Inc. stock logo
FANG
Diamondback Energy
Morgan Stanley logo
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeOverweight ➝ Equal Weight$216.00
8/19/2026
Diamondback Energy, Inc. stock logo
FANG
Diamondback Energy
Morgan Stanley logo
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight ➝ Equal Weight$216.00
8/19/2026
Moderna, Inc. stock logo
MRNA
Moderna
Bank of America Corporation logo
Bank of America
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeUnderperform ➝ Neutral
8/19/2026
Moderna, Inc. stock logo
MRNA
Moderna
William Blair logo
William Blair
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform
8/17/2026
Diamondback Energy, Inc. stock logo
FANG
Diamondback Energy
Barclays PLC logo
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOverweight$232.00 ➝ $221.00
(Data available from 8/19/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Diamondback Energy, Inc. stock logo
FANG
Diamondback Energy
$15.03B3.89$30.90 per share6.75$157.08 per share1.33
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$125.10B2.38$63.42 per share16.12$376.80 per share2.71
Moderna, Inc. stock logo
MRNA
Moderna
$1.94B35.81N/AN/A$16.93 per share10.30
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Diamondback Energy, Inc. stock logo
FANG
Diamondback Energy
$1.66B$5.1340.6512.03N/A8.58%10.10%6.16%11/2/2026 (Estimated)
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$17.18B$64.7915.7814.151.0515.53%19.16%1.07%10/13/2026 (Estimated)
Moderna, Inc. stock logo
MRNA
Moderna
-$2.82B-$7.99N/AN/AN/A-141.43%-28.30%-19.39%11/5/2026 (Estimated)

Latest FANG, GS, and MRNA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/3/2026Q2 2026
Diamondback Energy, Inc. stock logo
FANG
Diamondback Energy
$6.08$6.48+$0.40$6.65$4.89 billion$5.56 billion
7/31/2026Q2 2026
Moderna, Inc. stock logo
MRNA
Moderna
-$2.03-$1.97+$0.06-$1.97$102.93 million$145.00 million
7/14/2026Q2 2026
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$14.47$20.98+$6.51$20.98$16.22 billion$20.34 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Diamondback Energy, Inc. stock logo
FANG
Diamondback Energy
$4.402.11%+21.67%85.77%7 Years
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$18.001.76%+22.87%27.78%13 Years
Moderna, Inc. stock logo
MRNA
Moderna
N/AN/AN/AN/AN/A

Latest FANG, GS, and MRNA Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/13/2026
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
quarterly$5.001.75%9/1/20269/1/20269/29/2026
7/30/2026
Diamondback Energy, Inc. stock logo
FANG
Diamondback Energy
quarterly$1.102.21%8/13/20268/13/20268/20/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Diamondback Energy, Inc. stock logo
FANG
Diamondback Energy
0.25
0.47
0.45
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
3.17
0.63
0.63
Moderna, Inc. stock logo
MRNA
Moderna
0.09
2.29
2.18

Institutional Ownership

CompanyInstitutional Ownership
Diamondback Energy, Inc. stock logo
FANG
Diamondback Energy
90.01%
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
71.21%
Moderna, Inc. stock logo
MRNA
Moderna
75.33%

Insider Ownership

CompanyInsider Ownership
Diamondback Energy, Inc. stock logo
FANG
Diamondback Energy
0.64%
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
0.55%
Moderna, Inc. stock logo
MRNA
Moderna
10.80%
CompanyEmployeesShares OutstandingFree FloatOptionable
Diamondback Energy, Inc. stock logo
FANG
Diamondback Energy
1,762280.02 million278.23 millionOptionable
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
47,400291.17 million289.57 millionOptionable
Moderna, Inc. stock logo
MRNA
Moderna
4,700399.24 million356.12 millionOptionable

Recent News About These Companies

Why Moderna Stock Skyrocketed Today
 |  fool.comhttps://www.fool.com/investing/2026/08/19/why-moderna-stock-skyrocketed-today/
Moderna (MRNA)’s Melanoma Vaccine Win: Big Opportunity, Bigger Expectations
 |  insidermonkey.comhttps://www.insidermonkey.com/blog/moderna-mrnas-melanoma-vaccine-win-big-opportunity-bigger-expectations-1818038/
Merck, Moderna Cancer Vaccine Breakthrough Could Be Catalyst the mRNA ETF Trade Has Been Waiting For
August 19 at 5:49 PM  |  benzinga.comhttps://www.benzinga.com/etfs/sector-etfs/26/08/61318160/merck-moderna-cancer-vaccine-breakthrough-could-be-catalyst-the-mrna-etf-trade-has-been-waiting-for?utm_source=snapi
Opinion | Moderna's Road to a Cancer Vaccine
August 19 at 5:45 PM  |  wsj.comhttps://www.wsj.com/opinion/moderna-mrna-vaccine-melanoma-cancer-53c74c37
SLS Stock Edges Higher As Wall Street, Retail Expect Another MRNA Moment
August 19 at 5:37 PM  |  stocktwits.comS
Merck (MRK) Stock Trades Up, Here Is Why
August 19 at 5:37 PM  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/merck-mrk-stock-trades-why-211802199.html
BioNTech Stock Surges 20% on Moderna Cancer Vaccine Win. Why the Gains Could Fade.
August 19 at 5:37 PM  |  finance.yahoo.comhttps://finance.yahoo.com/m/54926def-c88c-3783-9c11-a0a6c00b7bed/biontech-stock-surges-20%25-on.html
Moderna, Merck melanoma cancer vaccine is a 'grand slam': Dr. Ezekiel Emanuel
August 19 at 5:37 PM  |  finance.yahoo.comhttps://finance.yahoo.com/video/moderna-merck-melanoma-cancer-vaccine-is-a-grand-slam-dr-ezekiel-emanuel-202500008.html
Moderna or Merck: Which Soaring Cancer Vaccine Stock Is the Better Buy?
August 19 at 5:36 PM  |  zacks.comhttps://www.zacks.com/commentary/2977221/moderna-or-merck-which-soaring-cancer-vaccine-stock-is-the-better-buy?cid=cs-stocknewsapi-ft-investment_ideas-2977221
Moderna, Merck breakthrough could usher in wave of cancer vaccines
August 19 at 4:58 PM  |  reuters.comhttps://www.reuters.com/legal/litigation/moderna-merck-breakthrough-could-usher-wave-cancer-vaccines-2026-08-19/
U.S. Stocks Gain as Treasury Buybacks Calm Bond Yields; Moderna Surges
August 19 at 4:28 PM  |  wsj.comhttps://www.wsj.com/finance/stocks/u-s-stocks-gain-as-treasury-buybacks-calm-bond-yields-moderna-surges-402249fb
Value Stocks Worth Watching - August 19th
August 19 at 3:01 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/value-stocks-worth-watching-august-19th-2026-08-19/
Technology Stocks To Follow Today - August 19th
August 19 at 3:00 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/technology-stocks-to-follow-today-august-19th-2026-08-19/
Moderna's Cancer Breakthrough Just Made Tempus AI's $1.5 Billion Bet Look Brilliant
August 19 at 2:44 PM  |  247wallst.comhttps://247wallst.com/investing/2026/08/19/modernas-cancer-breakthrough-just-made-tempus-ais-1-5-billion-bet-look-brilliant/?utm_source=snapi
Moderna (NASDAQ:MRNA) Raised to "Neutral" at Bank of America
August 19 at 2:05 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/moderna-nasdaqmrna-raised-to-neutral-at-bank-of-america-2026-08-19/
$1,000 invested in Moderna stock a week ago is now worth
August 19 at 1:45 PM  |  finbold.comF
Moderna Sees Unusually High Options Volume (NASDAQ:MRNA)
August 19 at 1:19 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/moderna-sees-unusually-high-options-volume-nasdaqmrna-2026-08-19/
From COVID to Cancer: Moderna Scores Melanoma Breakthrough
August 19 at 1:16 PM  |  zacks.comhttps://www.zacks.com/commentary/2977096/from-covid-to-cancer-moderna-scores-melanoma-breakthrough?cid=cs-stocknewsapi-ft-investment_ideas-2977096
Moderna Stock Jumps 86% on First mRNA Cancer Trial Win
August 19 at 12:37 PM  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/moderna-stock-jumps-86-first-144644104.html
Moderna shares soar as mRNA cancer vaccine succeeds in late-stage trial
August 19 at 12:37 PM  |  proactiveinvestors.comhttps://www.proactiveinvestors.com/companies/news/1097284/moderna-shares-soar-as-mrna-cancer-vaccine-succeeds-in-late-stage-trial-1097284.html
Moderna shares surge after it says its experimental mRNA cancer treatment passed a key test
August 19 at 12:37 PM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/moderna-shares-surge-says-experimental-154154724.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
AMD logo on a glowing processor chip with red circuit traces, highlighting AI and data-center semiconductor demand.
AMD’s AI Bubble Could Burst Into Explosive Upside
By Thomas Hughes | July 27, 2026
SpaceX logo beside a rocket on a launch pad at sunset, with a colorful sky in the background.
SpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have Control
By Jeffrey Neal Johnson | August 3, 2026
SK hynix logo above a robotic arm placing memory chips on a wafer in a server data center.
Why SK hynix Could Be the Best AI Chip Stock to Buy Now
By Thomas Hughes | July 29, 2026
SoundHound AI logo displayed within a glowing orange ring against a dark background with light wave effects.
SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat
By Thomas Hughes | August 10, 2026
A Patriot missile launcher and soldier on an airbase tarmac as an F-35 fighter jet flies overhead at sunset.
RTX and Lockheed Earnings: Can Strong Guidance Reset the Defense Trade?
By Dan Schmidt | July 26, 2026
Diamondback Energy stock logo

Diamondback Energy NASDAQ:FANG

$208.55 -1.47 (-0.70%)
Closing price 04:00 PM Eastern
Extended Trading
$209.63 +1.08 (+0.52%)
As of 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Diamondback Energy, Inc., an independent oil and natural gas company, acquires, develops, explores, and exploits unconventional, onshore oil and natural gas reserves in the Permian Basin in West Texas. It focuses on the development of the Spraberry and Wolfcamp formations of the Midland basin; and the Wolfcamp and Bone Spring formations of the Delaware basin, which are part of the Permian Basin in West Texas and New Mexico. The company also owns and operates midstream infrastructure assets, in the Midland and Delaware Basins of the Permian Basin. Diamondback Energy, Inc. was founded in 2007 and is headquartered in Midland, Texas.

The Goldman Sachs Group stock logo

The Goldman Sachs Group NYSE:GS

$1,022.32 -18.16 (-1.74%)
Closing price 03:59 PM Eastern
Extended Trading
$1,024.28 +1.96 (+0.19%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

The Goldman Sachs Group, Inc., a financial institution, provides a range of financial services for corporations, financial institutions, governments, and individuals worldwide. It operates through Global Banking & Markets, Asset & Wealth Management, and Platform Solutions segments. The Global Banking & Markets segment provides financial advisory services, including strategic advisory assignments related to mergers and acquisitions, divestitures, corporate defense activities, restructurings, and spin-offs; and relationship lending, and acquisition financing, as well as secured lending, through structured credit and asset-backed lending and involved in financing under securities to resale agreements. This segment also offers client execution activities for cash and derivative instruments; credit and interest rate products; and provision of mortgages, currencies, commodities, and equities related products, as well as underwriting services. The Asset & Wealth Management segment manages assets across various classes, including equity, fixed income, hedge funds, credit funds, private equity, real estate, currencies, and commodities; and provides customized investment advisory solutions, wealth advisory services, personalized financial planning, and private banking services, as well as invests in corporate equity, credit, real estate, and infrastructure assets. The Platform Solutions segment offers credit cards and point-of-sale financing for purchase of goods or services. This segment also provides cash management services, such as deposit-taking and payment solutions for corporate and institutional clients. The Goldman Sachs Group, Inc. was founded in 1869 and is headquartered in New York, New York.

Moderna stock logo

Moderna NASDAQ:MRNA

$174.38 +111.42 (+176.97%)
Closing price 04:00 PM Eastern
Extended Trading
$166.34 -8.04 (-4.61%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas